Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (901-910 of 1,011) with videos related to

Pageof 102
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 6, 2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertensionAlexander G Vandell, Maximilian T Lobmeyer, Brian E Gawronski, et al.
BMC Microbiology|February 18, 2021
Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infectionsTimothy J Straub, Wen-Chi Chou, Abigail L Manson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Frontiers in Microbiology|September 7, 2018
Phylogenomic Classification and the Evolution of Clonal Complex 5 Methicillin-Resistant <i>Staphylococcus aureus</i> in the Western HemisphereLavanya Challagundla, Jinnethe Reyes, Iftekhar Rafiqullah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanomaMiguel-Angel Perales, Jianda Yuan, Sarah Powel, et al.
Stem Cell Research|January 24, 2012
Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomesWalter D Funk, Ivan Labat, Janani Sampathkumar, et al.
Melanoma Research|October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanomaAlexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United StatesLawrence Flaherty, Omid Hamid, Gerald Linette, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
Pageof 102

Showing results (901-910 of 1,011) with videos related to

Sort By:
Pageof 102
Hypertension (Dallas, Tex. : 1979)|September 6, 2012
G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertensionAlexander G Vandell, Maximilian T Lobmeyer, Brian E Gawronski, et al.
BMC Microbiology|February 18, 2021
Limited effects of long-term daily cranberry consumption on the gut microbiome in a placebo-controlled study of women with recurrent urinary tract infectionsTimothy J Straub, Wen-Chi Chou, Abigail L Manson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 21, 2012
Kidney volume and functional outcomes in autosomal dominant polycystic kidney diseaseArlene B Chapman, James E Bost, Vicente E Torres, et al.
Frontiers in Microbiology|September 7, 2018
Phylogenomic Classification and the Evolution of Clonal Complex 5 Methicillin-Resistant <i>Staphylococcus aureus</i> in the Western HemisphereLavanya Challagundla, Jinnethe Reyes, Iftekhar Rafiqullah, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 18, 2008
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanomaMiguel-Angel Perales, Jianda Yuan, Sarah Powel, et al.
Stem Cell Research|January 24, 2012
Evaluating the genomic and sequence integrity of human ES cell lines; comparison to normal genomesWalter D Funk, Ivan Labat, Janani Sampathkumar, et al.
Melanoma Research|October 30, 2016
Clinical features and response to systemic therapy in a historical cohort of advanced or unresectable mucosal melanomaAlexander N Shoushtari, Mark J Bluth, Debra A Goldman, et al.
Cancer Journal (Sudbury, Mass.)|January 22, 2014
A single-arm, open-label, expanded access study of vemurafenib in patients with metastatic melanoma in the United StatesLawrence Flaherty, Omid Hamid, Gerald Linette, et al.
Kidney International Reports|April 29, 2021
Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney DiseaseMireille El Ters, Pengcheng Lu, Jonathan D Mahnken, et al.
Kidney International|November 25, 2003
Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney diseaseBernard F King, Vicente E Torres, Marijn E Brummer, et al.
Pageof 102